http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2006059768-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C401-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-12 |
| filingDate | 2005-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2006059768-A1 |
| titleOfInvention | 9,10-secopregnane derivatives and medicaments |
| abstract | The object is to provide a novel and useful vitamin D3 derivative having excellent vitamin D3 activity and little influence on systemic calcium metabolism. Examples of the present invention include 9,10-secopregnane derivatives represented by the following general formula [1] and pharmaceutical compositions containing them as active ingredients. [Chemical 1] In general formula [1], Y represents (1) a single bond, (2) alkylene, (3) alkenylene, or (4) phenylene, and R 1 and R 2 are the same or different and are (1) hydrogen, (2) alkyl, Or (3) represents cycloalkyl, or R 1 and R 2 together with adjacent carbon atoms represent cycloalkyl, R 3 represents hydrogen or methyl, and Z represents (1 ) Represents hydrogen, (2) hydroxy, or (3) —NR 11 R 12 . |
| priorityDate | 2004-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 155.